HAYWARD, Calif., Jan. 12, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced the promotion of Thomas Yorkey, Ph.D., to Vice President of Research & Development, Dr. Yorkey will lead all global R&D initiatives and will report to Clint Carnell, Chief Operating Officer at Solta.
"Tom has made an immediate impact since joining the company, leading our advanced development initiatives," said Mr. Carnell. "With more than 20 years of experience in the medical device industry, Tom possesses the leadership and technology development skills to aggressively lead our efforts in bringing to market new and innovative products and procedures that will benefit both our doctors and their patients around the world."
Dr. Yorkey has experience in leading companies from startups to multi-nationals which include Nellcor Puritan Bennett, a division of Tyco Healthcare where he served as VP of Research and Development. He holds a Ph.D. in Electrical Engineering from the University of Wisconsin, Madison and a Bachelor of Science degree in Electrical Engineering from the State University of New York at Buffalo. Dr. Yorkey also sits on the Board of Directors of Hunter Technologies, a private Electronic Manufacturing Services company.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's four premier brands: Thermage®, Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers min
|SOURCE Solta Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved